Cite
Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell administration.
MLA
Sýkorová, Alice, et al. “Several Factors That Predict the Outcome of Large B‐cell Lymphoma Patients Who Relapse/Progress after Chimeric Antigen Receptor (CAR) T‐cell Therapy Can Be Identified before Cell Administration.” Cancer Medicine, vol. 13, no. 17, Sept. 2024, pp. 1–15. EBSCOhost, https://doi.org/10.1002/cam4.70138.
APA
Sýkorová, A., Folber, F., Polgárová, K., Móciková, H., Ďuraš, J., Steinerová, K., Obr, A., Heindorfer, A., Ladická, M., Lukáčová, Ľ., Čellárová, E., Plameňová, I., Belada, D., Janíková, A., Trněný, M., Jančárková, T., Procházka, V., Vranovský, A., Králiková, M., & Vydra, J. (2024). Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell administration. Cancer Medicine, 13(17), 1–15. https://doi.org/10.1002/cam4.70138
Chicago
Sýkorová, Alice, František Folber, Kamila Polgárová, Heidi Móciková, Juraj Ďuraš, Kateřina Steinerová, Aleš Obr, et al. 2024. “Several Factors That Predict the Outcome of Large B‐cell Lymphoma Patients Who Relapse/Progress after Chimeric Antigen Receptor (CAR) T‐cell Therapy Can Be Identified before Cell Administration.” Cancer Medicine 13 (17): 1–15. doi:10.1002/cam4.70138.